Journals / Adli Tıp Dergisi / 2007 / Cilt: 21 - Sayı: 1

Canavan disease :An automosal recessive leukodistrophy identified at autopsy

Bir otopsi olgusunda otosomal çekinik Lökodistrofi: Canavan hastalığı

Pages
27–31
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of our study is to determine morphological changes of this disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Canavan disease is a very rare autosomal recessive leukodistrophy characterized by spongiform degeneration of the white matter.
📊
Key Findings & Data:The aspartoacylase gene localized on the short arm of chromosome 17.
💡
Conclusion & Impact:The aim of our study is to determine morphological changes of this disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Canavan disease is a very rare autosomal recessive leukodistrophy characterized by spongiform degeneration of the white matter. Disease is caused by mutations in the aspartoacylase gene which lead to deficiency of aspartoacylase enzyme activity. The aspartoacylase gene localized on the short arm of chromosome 17. Like all other Leukodystrophies Canavan disease is also considered within the metabolic disorders may cause sudden and unexpected deaths especially in childhood. The aim of our study is to determine morphological changes of this disease.

Özet

Canavan hastalığı, beyaz cevherin spongiform dejenerasyonu ile kendini gösteren nadir görülen otosomal çekinik (resesif) bir lökodistrofidir. 17. kromozomun kısa kolunda lokalize bir genin mutasyonunun neden olduğu aspartoasiiaz enzim eksikliğinin bu hastalıktan sorumlu olduğu düşünülmektedir. Çalışmamızın amacı, özellikle çocukluk çağında, ani ve şüpheli ölüm nedeni olarak karşımıza çıkabilecek metabolik hastalıklardan biri olan Canavan hastalığında beyinde saptanan morfolojik değişiklikleri, olgunun klinik özellikleri ile birlikte ortaya koymaktır.

🔖

Cite This Article

SAV, A., KARAYEL, F., TURAN, A. A., ÖZATA, B., KÜRKÇÜ, D., PAKİŞ, I. (2022). Canavan disease :An automosal recessive leukodistrophy identified at autopsy. Adli Tıp Dergisi, Cilt: 21 - Sayı: 1, 27–31. https://ajindex.com/articles/428858

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Gordon N. Canavan Disease: A review of recent developments. Eur J Pediatr Neurol, 2000;5:65-69. 2.Harding BN, Surtees R. Metabolic and neurodegenerative diseases of childhood. In Graham Dİ, Lantos PL eds. Greenfield's Neuropathology voli,7th ed. London: Arnold; 2002: 485-511. 3.Ellison D, Love S, Harding BN, Lowe J, Vinters HV eds.Disorders that primarily affect white matter. Neuropathology, 2nd ed.London, Mosby;2004:119-129. 4.Aydınlı N, Çalışkan M, Calay M, Özmen M. Use of localized proton nuclear magnetic resonance spectroscopy in Canavan's disease. Turk J Pediatr, 1998; 40: 549-557. 5.Matalon R, Michals K, Sebasta D, Deanching M, Gashkoff P, Casanova J. Aspartoacylase deficiency and N- acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet,1988;29:463-471. 6.Burlina AP, Ferrari V, Divry P, Gradowska W, Jakobs C, Bennett MJ, Sewell AC, Dionisi -Vici C, Burlina AB. N-asetylaspartylglutamate in Canavan disease: an adverse effector? Eur J Pediatr, 1999; 158:406-409. 7.Baslow MH, Suckow RF, Sapirstein V, Hungund BL. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Molec Neurosci, 1999;13: 47-50. 8.Mejaski- Bosnjak V, Besenski N, Brockmann K, Pouwels PJW, Frahm J, Hanefeld FA. Cystic leukoencephalopathy in a megaiencephalic child: clinical and magnetic resonance imaging/magnetic resonance spectroscopy findings. Pediatr Neurol,1997; 16: 347-350.